Todd Laughlin

Todd Laughlin is an experienced professional in the field of molecular diagnostics and genomics, currently serving as an Account Manager at QIAGEN since 2017, where responsibilities include providing next-generation sequencing (NGS), PCR, and other genomics solutions to clinical customers in Southern California, Arizona, and New Mexico. Prior to this role, Todd held positions as a Senior Field Applications Specialist at QIAGEN, and as a Molecular Diagnostics Consultant at siParadigm L.L.C, where advisory work focused on optimizing and validating clinical laboratory developed tests (LDT) and preparing regulatory submission packages. Todd's career began at the University of Rochester Medical Center, contributing to the development, validation, and implementation of nucleic acid-based assays, as well as clinical research efforts. Additional experience includes roles at Ortho Clinical Diagnostics and Pfizer, specializing in the development of nucleic acid-based diagnostic assays and conducting research. Todd holds a Bachelor's degree in Biochemical Pharmacology from the University at Buffalo.